Intra-Cellular Therapies, Inc.

Pharmaceutical Preparations·BEDMINSTER, NJ

Financials

20 shown

Type	Period	Ended	Filed
10-K/A	FY 2024	12/31/24	3/20/25	→
10-K	FY 2024	12/31/24	2/21/25	→
10-Q	Q3 2024	9/30/24	10/30/24	→
10-Q	Q2 2024	6/30/24	8/7/24	→
10-Q	Q1 2024	3/31/24	5/7/24	→
10-K	FY 2023	12/31/23	2/22/24	→
↓

Earnings Releases (8-K)

30 shown

Filed	Period
2/21/25	Q1 FY2025	→
10/30/24	Q3 FY2024	→
8/7/24	Q3 FY2024	→
5/7/24	Q2 FY2024	→
4/16/24	Q1 FY2024	→
2/22/24	Q1 FY2024	→
↓

News (8-K)

50 shown

Filed	Type	Description
4/2/25	Delisting	Completion of Acquisition or Disposition of Assets	→
3/27/25	Vote	Submission of Matters to a Vote of Security Holders	→
3/18/25	Other	Other Events	→
3/3/25	Other	Other Events	→
1/13/25	Agreement	Entry into a Material Definitive Agreement	→
1/10/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
4/2/25	POSASR	POSASR	→
4/2/25	S-8 POS	S-8 POS	→
4/2/25	S-8 POS	S-8 POS	→
4/2/25	S-8 POS	S-8 POS	→
4/2/25	S-8 POS	S-8 POS	→
4/2/25	S-8 POS	S-8 POS	→
↓

Filing History(1002 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Jun 5, 2025

0000019617-25-000501

—

6.8 KB

15-12G

Apr 14, 2025

0001193125-25-07974215-12G

—

11.0 KB

EFFECT

Apr 9, 2025

9999999995-25-001048

—

1.8 KB

Apr 2, 2025

0000950170-25-0498304

Apr 2, 2025

29.9 KB

Apr 2, 2025

0000950170-25-0496484

Apr 2, 2025

24.2 KB

Apr 2, 2025

0000950170-25-0496464

Apr 2, 2025

26.6 KB

Apr 2, 2025

0000950170-25-0496364

Apr 2, 2025

26.3 KB

Apr 2, 2025

0000950170-25-0496274

Apr 2, 2025

24.6 KB

Apr 2, 2025

0000950170-25-0495964

Apr 2, 2025

14.1 KB

Apr 2, 2025

0000950170-25-0495954

Apr 2, 2025

36.7 KB

Apr 2, 2025

0000950170-25-0495934

Apr 2, 2025

30.7 KB

Apr 2, 2025

0000950170-25-0495924

Apr 2, 2025

12.7 KB

POSASR

Apr 2, 2025

0001193125-25-071392POSASR

—

20.5 KB

S-8 POS

Apr 2, 2025

0001193125-25-071368S-8 POS

—

26.3 KB

S-8 POS

Apr 2, 2025

0001193125-25-071365S-8 POS

—

26.3 KB

S-8 POS

Apr 2, 2025

0001193125-25-071360S-8 POS

—

26.3 KB

S-8 POS

Apr 2, 2025

0001193125-25-071359S-8 POS

—

26.3 KB

S-8 POS

Apr 2, 2025

0001193125-25-071353S-8 POS

—

26.3 KB

S-8 POS

Apr 2, 2025

0001193125-25-071334S-8 POS

—

26.3 KB

POS AM

Apr 2, 2025

0001193125-25-071328POS AM

—

20.1 KB

8-K

Apr 2, 2025

0001193125-25-0713258-K

Apr 2, 2025

319.7 KB

25-NSE

Apr 2, 2025

0001354457-25-000272

—

3.0 KB

Mar 31, 2025

0000950170-25-0479374

Mar 26, 2025

6.5 KB

8-K

Mar 27, 2025

0001193125-25-0655078-K

Mar 27, 2025

154.4 KB

10-K/A

Mar 20, 2025

0001628280-25-01415410-K/A

Dec 31, 2024

1.6 MB

25 filings shown

Filed	Form	Description
2/18/25	DEFM14A	DEFM14A	→
2/5/25	PREM14A	PREM14A	→
1/13/25	DEFA14A	DEFA14A	→
1/13/25	DEFA14A	DEFA14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
↓

Intra-Cellular Therapies, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1002 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/14/25	15-12G	15-12G	→
4/9/25	EFFECT	EFFECT	→
4/2/25	POS AM	POS AM	→
4/2/25	25-NSE	25-NSE	→
3/18/25	144	144	→
↓